FealtySign in

STERIS plc

(STE)

CIK 1757898 · SEC filings only

Not gradedDividend record
shown as history
company entity
25 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

25 declarations · 8 raised · 16 held · 0 cut · held 24 quarters

  1. HELD$0.6300/shperiod ended 2026-06-30Filing ↗
  2. HELD$0.6300/shperiod ended 2025-12-31Filing ↗
  3. RAISED$0.6300/shperiod ended 2025-09-30Filing ↗
  4. HELD$0.5700/shperiod ended 2025-06-30Filing ↗
  5. HELD$0.5700/shperiod ended 2024-12-31Filing ↗
  6. RAISED$0.5700/shperiod ended 2024-09-30Filing ↗
  7. HELD$0.5200/shperiod ended 2024-06-30Filing ↗
  8. HELD$0.5200/shperiod ended 2023-12-31Filing ↗
  9. RAISED$0.5200/shperiod ended 2023-09-30Filing ↗
  10. HELD$0.4700/shperiod ended 2023-06-30Filing ↗
  11. HELD$0.4700/shperiod ended 2022-12-31Filing ↗
  12. RAISED$0.4700/shperiod ended 2022-09-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
0 resolved promises

Not enough resolved promises to grade

0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

buyback history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

STERIS's Board of Directors has authorized a new share buyback program for the purchase of up to $1 billion of the Company's ordinary shares

resolves in ~605 days$1.00Breceipt →
0 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
CGuidance record
grade
company entity
5 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (21)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance fy · Aug 5, 2026
    Adjusted earnings per diluted share are anticipated to be in the range of $11.10 to $11.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. revenue guidance fy · Aug 5, 2026
    constant currency organic revenue growth of 6-7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · May 11, 2026
    Adjusted earnings per diluted share is anticipated to be in the range of $11.10 to $11.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Feb 4, 2026
    Adjusted earnings per diluted share from continuing operations are expected to be in the range of $10.15 to $10.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Nov 5, 2025
    Adjusted earnings per diluted share from continuing operations are also increasing and are now expected to be in the range of $10.15 to $10.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Aug 6, 2025
    Adjusted earnings per diluted share from continuing operations is also unchanged in the range of $9.90 to $10.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · May 14, 2025
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.90 to $10.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Feb 5, 2025
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.05 to $9.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Aug 6, 2024
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.05 to $9.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. revenue guidance fy · Aug 6, 2024
    Constant currency organic revenue from continuing operations is anticipated to increase 6-7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Nov 7, 2023
    Adjusted earnings per diluted share are anticipated to be in the range of $8.60 to $8.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Feb 8, 2023
    adjusted earnings per diluted share are now anticipated to be in the range of $8.00 to $8.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Nov 9, 2022
    The adjusted earnings per diluted share range of $8.40 to $8.60 remains unchanged
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · May 12, 2022
    Adjusted earnings per diluted share are anticipated to be in the range of $8.55 to $8.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. revenue guidance fy · Feb 8, 2022
    Constant currency organic revenue growth is now anticipated to be approximately 11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Feb 8, 2022
    Adjusted earnings per diluted share are now anticipated to be in the range of $7.85 to $7.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. revenue guidance fy · Nov 2, 2021
    constant currency organic revenue growth in the range of 10-11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Nov 2, 2021
    adjusted earnings per share of $7.60 to $7.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. revenue guidance fy · Aug 9, 2021
    Constant currency organic revenue growth is now expected to be in the range of 10-11% for fiscal 2022
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Aug 9, 2021
    Adjusted earnings per diluted share are anticipated to be in the range of $7.60 - $7.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · May 18, 2021
    Adjusted earnings per diluted share are anticipated to be in the range of $7.40 - $7.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (4) · 9 superseded

Open · revenue guidance fy

We are well positioned to finish another record year in revenue and income during fiscal 2021

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Constant currency organic revenue is now anticipated to grow approximately 7%

unresolved — no outcome on file$7.0000receipt →
Open · revenue guidance fy

revenue growth of 9-10%

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

as reported revenue growth of 7-8%

resolves in ~564 daysreceipt →
Superseded · revenue guidance fy

For fiscal 2027, the Company expects as reported revenue to increase 7-8%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 8-9%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

As reported revenue is expected to increase approximately 12%

revised by a later guidance$12.0000receipt →
Superseded · revenue guidance fy

the Company now expects as reported revenue from continuing operations to increase 8-9%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Constant currency organic revenue growth is expected to be in the range of 8-9% for fiscal 2022.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

STERIS expects as reported revenue of approximately $4.5 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 6-7%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For fiscal 2025, the Company continues to expect as reported revenue from continuing operations to increase 6.5-7.5%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

as reported revenue is now anticipated to grow 8%

revised by a later guidancereceipt →

Credibility timeline

MISSED · May 31, 2022BEAT · May 26, 2023MISSED · May 29, 2024BEAT · May 29, 2025KEPT · May 29, 2026
20222026
Timeline as a list
  • May 31, 2022MISSEDSTERIS now expects as reported revenue of approximately $4.6 billion
  • May 26, 2023BEATAs reported revenue is now anticipated to grow 6%
  • May 29, 2024MISSEDconstant currency organic revenue growth of 6-7%
  • May 29, 2025BEATFor fiscal 2025, the Company now expects as reported revenue to increase approximately 6%
  • May 29, 2026KEPTthe Company expects as reported revenue from continuing operations to increase 8-9%
5 resolved guidance promises · 21dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →